Literature DB >> 34695701

Grey-matter brain healthcare quotient and cognitive function: A large cohort study of an MRI brain screening system in Japan.

Keita Watanabe1, Shingo Kakeda2, Kiyotaka Nemoto3, Keiichi Onoda4, Shuhei Yamaguchi5, Shotai Kobayashi6, Yoshinori Yamakawa7.   

Abstract

There is sometimes a divergence between brain atrophy and impairments in cognitive function. The present study aimed to assess the relationship between cognitive function and the grey-matter brain healthcare quotient (GM-BHQ), which represents brain volume as a deviation value. In addition, we aimed to investigate lifestyle factors that can help maintain cognitive function despite brain atrophy. A total of 1,757 adults included in a Japanese MRI brain screening cohort underwent MRI. We classified the participants into two age groups: under 65 years old (young adult/middle age group) and over 64 years old (elder group). The GM-BHQ was more strongly correlated with cognitive function in the young adult/middle age group than in the elder group (p < .01). Regression analysis revealed that years of education was associated with the maintenance of cognitive function despite brain atrophy (p < .05). In conclusion, our findings suggest that the relationship between brain volume and cognitive function becomes more obscure with age.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Brain volume; Cognitive function; Dementia; GM-BHQ; Hippocampus; MRI

Mesh:

Year:  2021        PMID: 34695701     DOI: 10.1016/j.cortex.2021.09.009

Source DB:  PubMed          Journal:  Cortex        ISSN: 0010-9452            Impact factor:   4.027


  1 in total

1.  Effects of Obesity, Blood Pressure, and Blood Metabolic Biomarkers on Grey Matter Brain Healthcare Quotient: A Large Cohort Study of a Magnetic Resonance Imaging Brain Screening System in Japan.

Authors:  Keita Watanabe; Shingo Kakeda; Kiyotaka Nemoto; Keiichi Onoda; Shuhei Yamaguchi; Shotai Kobayashi; Yoshinori Yamakawa
Journal:  J Clin Med       Date:  2022-05-25       Impact factor: 4.964

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.